Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Trading began this week for the first companies on the Texas Stock Exchange, an upstart rival to the Nasdaq and New York Stock Exchange. The post The TXSE Launched Monday. It Aims To Make ‘Wall Street’ Less Relevant. appeared first…
Fund ownership of this Massachusetts tech firm is strong and growing. The post Macom Technology: Why This AI, Optical Networking Firm Eyes A New Potential Buy Point appeared first on Investor’s Business Daily.
Welcome to IBD Live! This list of FAQs and useful links will speed your learning curve. Some users have reported the inability to access the IBD Live show page on… Read More The post IBD Live Q&A, Two Key Stock…
Corcept Therapeutics, Stock Of The Day fell amid a medical sell-off, but has pared losses to near buy points. Earnings growth is booming. The post Corcept, IBD Stock Of The Day, Setting Up Amid Booming Earnings Growth appeared first on…
There’s a bidding war for a maker of a key hard-drive component, according to Bloomberg. The post Seagate And Western Digital Stocks Fall. There’s A New Twist To Toshiba Competition Fears. appeared first on Investor’s Business Daily.
Palo Alto stock exhibits great strength and sits right around an all-time high, making it a top choice for a bull put spread. The post Palo Alto Stock Is Ideal For This Long-Term Options Trade appeared first on Investor’s Business…
Option Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company for $5.8 billion. The post Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover appeared first on Investor’s Business Daily.
S&P 500 companies are on track to increase third-quarter earnings by 29.5% year over year. The post This Is Why The S&P 500 Is At Record Highs appeared first on Investor’s Business Daily.
Biotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. The post Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers appeared first on Investor’s Business Daily.
Drone, AI defense specialist Anduril wins $1.8 billion Army contract. CEO Palmer Luckey sees larger defense role. The post Anduril Wins $1.8 Billion Army Contract After CEO Luckey Takes Key DOD Role appeared first on Investor’s Business Daily.
